Global Yeast Infection Treatment Market Set to Surpass US$ 10031.3 Million by 2034, Forecasts Future Market Insights, Inc.
14 déc. 2023 08h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Dec. 14, 2023 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI) latest industry analysis, the global yeast infection treatment market is expected to reach US$ 6479.8...
Keravita Pro Review: Negative Side Effects or Real Benefits?
09 avr. 2021 20h35 HE
|
Marketing By Kevin
San Francisco, CA, April 09, 2021 (GLOBE NEWSWIRE) -- Healthy nails are a good indicator of a healthy lifestyle. One needs to learn how to improve on the conditions of this essential organ of the...
Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results
08 août 2019 16h07 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives, including immunotherapies, today reported financial...
Cidara Therapeutics to Host Investor Day on April 6, 2017
29 mars 2017 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, will host an Investor Day...
Cidara Reports First Quarter 2016 Financial Results and Provides Corporate Update
12 mai 2016 17h12 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 12, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Announces Participation in Leerink Partners 5th Annual Global Healthcare Conference
03 févr. 2016 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...